Managers / Q4 2022 · view latest →
MIRIA Asset Management Ltd
CIK 0001821462 · LEVEL 5, PORTOMASO BUSINESS TOWER, PORTOMASO, ST. JULIANS, O1, PTM 01 · 35620162117
Summary
Miria Asset Management Ltd reported $17M in U.S.-listed holdings across 6 positions for Q4 2022.
The portfolio is heavily concentrated: Store Cap alone accounts for 31.4% of reported value.
Compared with Q3 2022, the fund opened 4 new positions and exited 4.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 68.6% · $12M
- REIT · 31.4% · $5M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| COUPA SOFTWARE INC | NEW | +4.00M | 4.00M | +$4M | $4M |
| MAXAR TECHNOLOGIES INC | NEW | +68.0K | 68.0K | +$4M | $4M |
| APOLLO ENDOSURGERY INC | NEW | +165.7K | 165.7K | +$2M | $2M |
| ROGROGERS CORP | NEW | +13.1K | 13.1K | +$2M | $2M |
| LIBERTY MEDIA ACQUISITION CO | SOLD OUT | −973.3K | 0 | −$9M | $0 |
| AERIE PHARMACEUTICALS INC | SOLD OUT | −463.9K | 0 | −$7M | $0 |
| FORMA THERAPEUTICS HLDGS INC | SOLD OUT | −174.9K | 0 | −$3M | $0 |
| ACTIVISION BLIZZARD INC | SOLD OUT | −45.0K | 0 | −$3M | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2022
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | STORE CAP CORP | COM | 31.41% | $5M | 164.7K |
| 2 | COUPA SOFTWARE INC | COM | 23.03% | $4M | 4.00M |
| 3 | MAXAR TECHNOLOGIES INC | COM | 20.93% | $4M | 68.0K |
| 4 | APOLLO ENDOSURGERY INC | COM | 9.83% | $2M | 165.7K |
| 5 | ROGROGERS CORPhistory → | COM | 9.30% | $2M | 13.1K |
| 6 | MXMAGNACHIP SEMICONDUCTOR CORPhistory → | COM | 5.51% | $926,324 | 98.7K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2024 | $50M | 11 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $38M | 8 | Aug 9, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $16M | 4 | May 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $18M | 6 | Feb 14, 2024 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2023 | $117M | 7 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $39M | 7 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $49M | 6 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $17M | 6 | Feb 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $28M | 6 | Nov 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $81M | 6 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $106M | 11 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $111M | 11 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $168M | 30 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $243M | 27 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $218M | 31 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $75M | 8 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $109M | 14 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $51M | 6 | Aug 18, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.